Related Experiment Video

Updated: Jul 31, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Clinical features of large granular lymphocyte leukemia

Thierry Lamy1, Thomas P Loughran

  • 1Department of Hematology, Pontchaillou University Hospital, Rennes, France.

Seminars in Hematology
|July 24, 2003
PubMed

Insights

Large granular lymphocyte (LGL) leukemias are lymphoid malignancies with T-cell or NK-cell origins. T-LGL leukemia is indolent, while NK-LGL leukemia is aggressive, impacting treatment strategies.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Large granular lymphocyte (LGL) proliferations encompass a spectrum from reactive expansion to aggressive leukemia.
  • LGL leukemias are lymphoid malignancies, primarily T-cell (85%) or NK-cell (15%) derived.
  • Leukemogenesis involves dysregulated survival signals in malignant LGLs.

Purpose of the Study:

  • To delineate the distinct entities within LGL proliferations.
  • To highlight recent advancements in understanding LGL leukemogenesis.
  • To describe diagnostic methods and clinical characteristics of T-LGL and NK-LGL leukemia.

Main Methods:

  • Utilizing T-cell receptor (TCR)beta/gamma polymerase chain reaction (PCR) for LGL expansion identification.
  • Employing Vbeta and killer cell immunoglobulin-like receptor (KIR)-specific monoclonal antibodies.
  • Assessing monoclonality through phenotypic, molecular, and karyotypic analyses.

Main Results:

  • LGL leukemias exhibit clonal infiltration of bone marrow, spleen, and liver.
  • T-LGL leukemia predominantly affects the elderly, presenting indolently with infections, anemia, and autoimmune diseases.
  • NK-LGL leukemia demonstrates aggressive behavior with poor response to chemotherapy.

Conclusions:

  • Accurate identification of LGL subtypes is crucial for prognostication and treatment.
  • T-LGL leukemia is manageable with immunosuppressive agents like methotrexate.
  • Aggressive NK-LGL leukemia necessitates alternative therapeutic approaches due to chemotherapy resistance.

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...